TherapeuticsMD: Clinical Trials

7 trials sponsored by TherapeuticsMD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated. 4 Phase 3, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1
Phase 12Completed 2
Phase 21Completed 1

Follow TherapeuticsMD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
Segesterone Acetate and Ethinyl Estradiol, Tampon - Contraception
Phase 1CompletedTherapeuticsMD212020-03-062021-10-29
Annovera™ Drug-Drug Interaction Study
Segesterone Acetate and Ethinyl Estradiol, Rifampin, Itraconazole - Women, Contraception
Phase 1CompletedTherapeuticsMD672020-02-122021-01-29
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
oral estradiol 1.0 mg, oral progesterone 100 mg - Menopause
Phase 3CompletedIntira Sriprasert202015-12-012020-03-19
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
Estradiol, Placebo - Vulvovaginal Atrophy, Menopause
Phase 3CompletedTherapeuticsMD7642014-09-012017-05-25
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Progesterone, Placebo - Secondary Amenorrhea
Phase 3TerminatedTherapeuticsMD62014-01-202018-05-08
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
Estradiol, Progesterone, Placebo - Menopause
Phase 3CompletedTherapeuticsMD18452013-08-052019-05-06
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
Estradiol, placebo - Menopause, Vulvovaginal Atrophy
Phase 2CompletedTherapeuticsMD502013-07-012015-12-14

Conditions studied

Dyspareunia (2)  ·  Hot Flashes (1)

Interventions

Estradiol (4)  ·  Progesterone (3)  ·  segesterone acetate and ethinyl estradiol vaginal system (2)  ·  Itraconazole (1)  ·  Rifampin (1)

Countries

United States (6)  ·  Canada (3)

Top investigators

Sebastian Mirkin, MD (3)  ·  David F Archer, MD (1)  ·  Shelli Graham, PhD (1)

Results publications

PMID 25835751, PMID 28355090, PMID 29889748, PMID 30238814, PMID 30586005, PMID 30601452, PMID 31364889, PMID 31688572, PMID 31913228, PMID 32740481, PMID 32932401, PMID 33110039, PMID 34054104, PMID 35213517, PMID 37619252, PMID 41291952